Floatz logo

Rosuvastatin

Atherosclerosis, Coronary

Ukrainian Medical Stomatological AcademySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Atherosclerosis, Coronary cohort.

Asset / SponsorPhaseRating
Bisoprolol Fumarate
Ukrainian Medical Stomatological Academy
Phase 4BB
ISOSORBIDE DINITRATE
Ukrainian Medical Stomatological Academy
Phase 4BB
Acetylsalicylic Acid
Ukrainian Medical Stomatological Academy
Phase 4BB
Pioglitazone
Ukrainian Medical Stomatological Academy
Phase 4BB
Ezetimibe
Samsung Medical Center
Phase 4BB
RAMIPRIL
Ukrainian Medical Stomatological Academy
Phase 4BB
Rimonabant
Sanofi
Phase 3CC
Edoxaban
Asan Medical Center
D

Same molecule, other indications

Rosuvastatin is also rated in:

inherited lipid metabolism disorderDormant
A
Indicative ·
81 / 100
View asset →
hyperlipidemiaDormant
BBB
Indicative ·
77 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →